Y
Yujie Liu
Researcher at Sun Yat-sen University
Publications - 15
Citations - 1293
Yujie Liu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Breast cancer & Metastasis. The author has an hindex of 10, co-authored 15 publications receiving 1007 citations. Previous affiliations of Yujie Liu include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells.
Mei Yang,Mei Yang,Jingqi Chen,Fang Su,Bin Yu,Fengxi Su,Ling Lin,Ling Lin,Yujie Liu,Jian-Dong Huang,Erwei Song +10 more
TL;DR: Macrophages regulate the invasiveness of breast cancer cells through exosome-mediated delivery of oncogenic miRNAs, which provides insight into the mechanisms underlying the metastasis-promoting interactions between macrophages and Breast cancer cells.
Journal ArticleDOI
MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.
Fengyan Yu,Yu Jiao,Yinghua Zhu,Ying Wang,Jingde Zhu,Xiuying Cui,Yujie Liu,Yinghua He,Eun Young Park,Hongyu Zhang,Xiao-Bin Lv,Kelong Ma,Fengxi Su,Jong Hoon Park,Erwei Song +14 more
TL;DR: In this paper, the expression and function of miR-34c were reduced in the BT-ICs of MCF-7 and SK-3rd cells, a breast cancer cell line enriched for BTICs.
Journal ArticleDOI
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
Qianfeng Shi,Yudong Li,Shunying Li,Liang Jin,Hongna Lai,Yanqing Wu,Zijie Cai,Mengdi Zhu,Qian Li,Ying Li,Jingru Wang,Yujie Liu,Zongqi Wu,Erwei Song,Qiang Liu +14 more
TL;DR: It is suggested DILA1 is a specific therapeutic target to downregulate Cyclin D1 protein and reverse tamoxifen resistance in treating breast cancer.
Journal ArticleDOI
Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition
TL;DR: It is shown that NKILA is down-regulated in TSCC cancer tissues than that in matched adjacent noncancerous tissues and this function could act as a potential predictor for overall survival in patients with TSCC and a potential therapeutic target for TSCC intervention.
Journal ArticleDOI
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
Yinghua Zhu,Yujie Liu,Chao Zhang,Junjun Chu,Yanqing Wu,Yudong Li,Jieqiong Liu,Qian Li,Shunying Li,Qianfeng Shi,Liang Jin,Jianli Zhao,Dong Yin,Sol Efroni,Fengxi Su,Herui Yao,Erwei Song,Qiang Liu +17 more
TL;DR: It is reported that tamoxifen-resistant breast cancer cells express significantly more BARD1 and BRCA1, leading to resistance to DNA-damaging chemotherapy including cisplatin and adriamycin, but not to paclitaxel.